RESCUE provides an inspiring, multidisciplinary and translational education programme in the area of Regenerative Medicine and Stem Cells. This programme aims to enhance the potential and future career perspectives of Early Stage Researchers (ESRs = PhD students) by providing a global training network including over 50 excellent academic and industrial partner organisations. Thereby, shaping a new generation of research experts, empowering them to take leading positions in the field of regenerative medicine world-wide:

  1. UMC Utrecht (coordinator) Hosting ESRs
  2. University Utrecht Hosting ESRs
  3. Hubrecht Institute Hosting ESRs
  4. Massachussetts Institute of Technology
  5. OcellO BV
  6. The Hebrew University University of Jerusalem
  7. Pepscan BV
  8. Delft University of Technology
  9. Delmic BV
  10. University of Copenhagen
  11. InteRNA technologies BV
  12. Gurdon Institute, University of Cambridge
  13. Leiden University Medical Center
  14. Noviocell BV
  15. Cystic Fibrosis Research Center University of Alabama
  16. Memorial Sloan kettering Cancer Center
  17. Mead Johnson Nutrition BV
  18. Histogenetics LLC
  19. Cedar-Sinai Medical Center
  20. Micalis Institute, UMR INRA- AgroParisTech University
  21. University Hospital Dresden
  22. Chiesi farmaceutici SPA
  23. Stanford Cardiovascular Institute
  24. LifeTec group BV
  25. Brigham and Women's Hospital, Harvard Medical School
  26. Micronit Microtechnologies B.V.
  27. Hannover Medical School
  28. Pharmahungary 2000 Ltd
  29. University of Technology Eindhoven
  30. Mimetas BV
  31. Viscofan Bioengineering GmbH
  32. Luxembourg Institute of Health
  33. University of Turino
  34. Aalborg University
  35. University of Saskatchewan
  36. University of Eastern Finland
  37. Nordic Bioscience A/S
  38. Orhtros TR BV i.o.
  39. KiOmed Pharma
  40. University Clinic W├╝rzburg
  41. RegenHU Biosystem ASA
  42. Chinese University of Hong Kong
  43. K2M Inc
  44. National Jewish Health
  45. Royal Philips Healthcare NV
  46. Semmelweis University
  47. Global Stem cell Technology NV
  48. University of New South Wales
  49. Kuros Biosciences BV
  50. University of British Columbia 
  51. AOSpine Knowledge Forum Tumor International 
  52. AO Research Institute Davos (ARI)
  53. 20Med Therapeutics BV
  54. Prince of Wales Hospital, CUHK
  55. MRI Guidance BV
  56. Hubrecht Organoid Technology


The H2020 MSCA COFUND projects have three types of partners:

1) Beneficiary:
The University Medical Centre Utrecht (UMC Utrecht) is the single beneficiary in this project. These H2020 MSCA COFUND projects have by default a one-beneficiary Grant Agreement with the EC.
2) Partner Organisations that appoint fellows:
Next to the UMC Utrecht, the Utrecht University and Hubrecht Institute have recruited and appointed ESRs in this project. With these two organisations the UMC Utrecht has agreed upon a Collaboration Agreement.
3) Partner Organisations that host secondments:
Partner Organisations that host secondments will not appoint ESRs, but provide research training during a short or longer stay. For these secondments a Secondment Agreement template has been set up to agree upon and to be signed.